Fig. 4
Variation of the cost of pathologies in 2021 compared with 2030. AMD: age-associated macular degeneration; DME: diabetic macular edema; DR: diabetic retinopathy; HM: high myopia
Fig. 4 | Health Economics Review
Variation of the cost of pathologies in 2021 compared with 2030. AMD: age-associated macular degeneration; DME: diabetic macular edema; DR: diabetic retinopathy; HM: high myopia